“showed a trend”

NFTs were also significantly associated with hippocampal body volume ( R = −0.34, P < 0.05) and the ERC thickness ( R = −0.36, P < 0.05) and showed a trend toward association with PHC thickness ( R = −0.28, P = 0.07).

FACS analysis showed that in LPS-injected mice treated with 1-PPA, only the activated CD8/totalCD8 ratio was significantly lower than in LPS-injected mice ( p = 0.048) ( Figure 6 D3), while the activated CD4/totalCD4 ratio showed a trend to be lower in untreated LPS-injected mice ( p = 0.07) ( Figure 6 D2).

and Body Weight, Tail Diameter, and BCS Body weight showed a trend toward association with Cryptosporidium infection ( p = 0.07) ( Table 1 ).

When these patients were separated out from the rest of the hyperselection MUT group, the remaining cohort who received Pmab showed a trend towards benefit compared to 5FU/LV alone [median PFS (mPFS) 11.6 vs. 5.0 months, HR =0.41; 95% CI: 0.16–1.05, P=0.07], which may suggest benefit from maintenance Pmab in non- BRAF V600E hyperselection MUT cases.

Analyses 14 days after reinfusion showed a trend (p=0.07) for higher total CD3+ counts with a median of 724x10 6 /L in responders compared to 182x10 6 /L in non-responders, count of CD3+ CAR cells with 105x10 6 /L and 14x10 6 /L (p=0.07) as well as CD3+/CD4+ cells with 291x10 6 /L and 70x10 6 /L, respectively, (p=0.10).

In the treated‐untreated comparison, the treated group showed a trend toward slower increases in CDR‐SB scores post‐treatment (ΔT=‐1.8, p = 0.07) compared to the untreated group (Figure 2).

The BED mean brain and BED mean healthy brain showed a trend toward a significant association with at least one resected BM (p = 0.07 and p = 0.1, respectively) and the number of SRT sessions (p = 0.14 and p = 0.13, respectively).

ASAL showed a trend (i.e., close to statistical significance; p = 0.07; Figure 8R ) towards ctsb down-regulation, which resulted in significantly lower mRNA levels in ASAL/no lice salmon than lice-infected salmon ( Figure 8H ).

Compared to patients on MT, those undergoing CA showed a trend towards a reduction in the composite endpoint (RR 0.59; (95% CI: 0.33–1.05); p = 0.07; I 2 = 17%) ( Figure 6 c) and a significative reduction in HF hospitalizations (RR 0.57; (95% CI: 0.41–0.78); p = 0.0006; I 2 = 0%) and AF recurrence (RR 0.35; (95% CI: 0.22–0.55); p < 0.00001; I 2 = 82%).

BDHI scores had a positive correlation with f P within the BD group (R = 0.63, P = .01), and BDI scores showed a trend toward positive correlation with f P (R = 0.42, P = .07).

All litters had lower ( p < 0.05) plasma IFNγ concentration on D63 compared to D0 except Litter 269–2F ( n = 8), which only showed a trend ( p = 0.07) toward decreased plasma IFNγ concentrations ( Figure 3C ).

The white adipocyte britening marker PRDM16 was upregulated ( Figure 3 G), while CIDEA showed a trend towards a larger expression ( p = 0.07).

Serum uric acid decreased significantly (p = 0.012), while haemoglobin showed a trend towards improvement (p = 0.070).

In addition, two-way ANOVA showed a trend for condition x set interaction ( p = 0.07, η 2 = 0.12).

The AIE group showed a trend toward increased time sniffing the novel object ( p = 0.07, Figure 5D ) with no differences in time sniffing the familiar object ( Figure 5E ).

NRF2 mRNA levels showed a trend toward decreasing in response to high glutamine ( P = 0.07) and increased after BPTES treatment, while GPX1 showed an opposite pattern ( Fig. 5 H and Supplementary Fig. 3 H ).

Replacement fibrosis expressed by LGE was present in 37 (74%) patients and only showed a trend towards a differentiation between the groups with and without nsVT ( p = 0.07).

Baseline β-CTX-I showed a trend toward predicting subsequent change (β = −0.34, p = 0.07), indicating that higher initial values were associated with greater reductions.

Based on Faith Phylogenetic diversity that assessed using the Tukey Honest Significant Difference method, the probable pigs had a higher phylogenetic diversity level compared to healthy pigs ( p = 0.045) and showed a trend towards greater diversity than the confirmed group ( p = 0.07) (Fig. 1 b).

The low‐dose acetylcholine endothelial dysfunction multivariate model showed a trend toward larger dysfunction in patients with hypertension ( P =0.070) and patients treated with bioresorbable‐polymer SESs ( P =0.083).

The meta-analysis showed a trend towards statistical significance between the experimental and control groups (−0.53, 95% CI [−1.11 to 0.05]; p = 0.07; I 2 = 86%) ( Figure 7 ).

Upregulated genes during indolmycin treatment showed a trend toward smaller sizes (−12.4% for 24 versus 10 hpi; P < 0.07), whereas upregulated genes during AN3365 treatment were significantly smaller (−15.4% for 24 versus 10 hpi; P < 0.05).

In men the LA-LV deviation angle showed a trend for greater angle (end-diastolic (ED) angle 26.9 ± 6.2° in women and 29.8 ± 5.9° in men, p = 0.07 and end-systolic (ES) angle 19.5 ± 5.9 and 22.6 ± 6.4, p = 0.06, respectively).

Of these variables, ABPI and urinary AER showed a trend towards predicting WMH after adjustment for aortic MAP, diabetes, lipids, smoking and alcohol volume (ß= -0·78, p=0·07 and ß= 0·17, p=0·08 respectively).

Underinsured patients had significantly higher rates of ICU admission (76.8% vs 52.5%, p < 0.01), longer ICU stays (5.2 ± 5.1 vs 3.1 ± 3.4 days, p = 0.02), and showed a trend toward higher mean costs (14,269 USD [52,847 AED] vs 11,133 USD [41,235 AED], p = 0.07).